Top News in R&D
 
 

 

 

READ ONLINE

 

 
 
 
 Global Health Technologies Coalition 
 
 
 
 

 

R&D News Roundup: August 7, 2023

 

Top News in R&D

Chance discovery helps fight against malaria
BBC (8/3)

Scientists have discovered that a naturally occurring strain of bacteria could help reduce the transmission of malaria by stopping the development of parasites in a mosquito’s gut. The bacteria, TC1, was found by chance when GSK scientists noticed that one of their mosquito colonies had stopped becoming infected with malaria parasites and later identified TC1 as the cause. Researchers have since observed that the bacteria works by secreting a small molecule, called harmane, which inhibits the parasite’s growth and that can be ingested by mosquitoes if mixed with sugar or absorbed by contact, opening the possibility for it to be used as an abatement tool. A recent study found that the bacteria can reduce a mosquito’s parasitic load by up to 73 percent, and trials in Burkina Faso are ongoing to assess the intervention’s effectiveness and safety in real-world settings.

Genetic variant linked to lower levels of HIV virus in people of African ancestry
MedicalXPress (8/2)

An international team of researchers has identified a genetic variant among some people of African ancestry that is associated with them having naturally lower viral loads of HIV—thereby slowing their illness progression and lowering the risk of them transmitting the virus. According to the researchers, this is the first new genetic variant related to HIV infection discovered within the last nearly 30 years. Between 4 to 13 percent of people of African origin are thought to carry this variant, which was discovered through an analysis of the DNA of almost 4,000 people of African ancestry infected with HIV-1. The scientists now intend to continue studies to more fully understand how exactly this variant impacts HIV replication.

How surging ‘breakbone fever’ threatens mothers and their unborn babies
The Telegraph (8/1), features the Drugs for Neglected Diseases initiative (DNDi)

Health experts are warning that dengue poses a danger to pregnant women, as new research has found that the disease can cause serious health complications for both mothers and their unborn babies. A recent study from the University of Surrey found that mild infection can make a pregnant individual 77 percent more likely to give birth before 32 weeks and can more than double the risk of the child being born with extremely low birth weight, which can affect brain development. This work builds on prior research that found pregnant women are three to four times more likely to die after becoming infected and 450 times more likely if their infection progresses into dengue hemorrhagic fever. There are currently no specific treatments for dengue, and existing vaccines are not recommended for pregnant women.

 

 

News from GHTC

Bill & Melinda Gates Foundation, Pfizer, expand partnership for greater access to injectable contraceptive for women In low- and lower-middle-income countries
All Africa (8/4), features the Bill & Melinda Gates Foundation, BD

New Vir CEO makes her mark, dropping small-molecule platform to 'judiciously' use $1.9B war chest
Fierce Biotech (8/4), features Vir Biotechnology

GARDP collaborates with ICMR to initiate study on status of antibiotic-resistant infections in hospitals
Financial Express (8/3), features Global Antibiotic Research and Development Partnership and DNDi

Mirvie receives $4.6 million grant from the Gates Foundation to study preeclampsia, a leading cause of maternal mortality worldwide
Forbes (8/3), features the Gates foundation

Injectable HIV treatment unlikely to be arriving soon in the global south
Aidsmap (8/2), features Medicines Patent Pool

Jeanne Marrazzo chosen to succeed Fauci as NIAID Director
MedPage Today (8/2), features AVAC and the Infectious Diseases Society of America (IDSA)
Related coverage in NPR (8/4), Vox (8/3), and Science (8/2) [features IDSA]

BD collects full FDA clearance for ‘tripledemic’ infection test
Fierce Biotech (8/1), features BD

 

 

Highlights From the Week

 

 

COVID-19 R&D Roundup

 

 

Upcoming Events